Hypomelanosis of Ito …

David T Hsieh MD

Developmental Malformations

Updated 12.14.2023
Released 06.10.1997
Expires For CME 12.14.2026

Hypomelanosis of Ito

Author: David T Hsieh MD

See Contributor Disclosures

Editor: Harvey B Sarnat MS MD FRCPC

Hypomelanosis of Ito

In This Article

Quick Link

Introduction

Overview

The term “hypomelanosis of Ito” encompasses a heterogeneous group of disorders characterized by hypopigmented skin lesions arranged in whorls, streaks, or both, along the lines of Blaschko. Even though Ito's original report in 1952 described a purely cutaneous disease, subsequent case reports and case series have recorded a significant association with multiple extracutaneous manifestations, including musculoskeletal and neurologic abnormalities. For hypomelanosis of Ito, several models of inheritance have been proposed but not proved, and a number of cytogenetic studies have revealed a wide variety of mosaic chromosomal abnormalities, hence, the heterogeneity of associated systemic features. Thus, it has been suggested that this group of conditions is rather a nonspecific manifestation reflecting genetic mosaicism. These mosaic phenomena likely disrupt expression or function of pigmentary genes.

Key points

	• Hypomelanosis of Ito is a sporadic neurocutaneous disorder characterized cutaneously by hypopigmented skin lesions arranged in whorls and streaks along the lines of Blaschko.
	• Though multisystem involvement is common, it is heterogeneous in presentation and commonly manifests with involvement of the neurologic and musculoskeletal systems.
	• The most common neurologic manifestations include cognitive and behavioral problems in up to 70% and epilepsy in up to 50%.
	• Neuroimaging findings can include cerebral or cerebellar atrophy, cerebral dysgenesis, or migrational abnormalities.

Historical note and terminology

Lines of Blaschko. Alfred Blaschko (1858 to 1922) was a private practitioner of dermatology in Berlin whose interests ranged from leprosy to occupational skin diseases (07).

Alfred Blaschko

(Contributed by Dr. Lorenzo Pavone.)

In 1901, he presented his original description of the distribution patterns of linear skin disorders after having examined more than 140 patients with linear lesions, such as epidermal nevi, sebaceous nevi, and nevus lipomatosus, and after carefully transposing the pattern in each patient onto dolls and statues (06; 31; 07).

Lines of Blaschko

Drawing of the "lines of Blaschko" originally obtained by Blaschko after examining more than 100 cases of congenital skin lesions distributed in mosaic patterns. (Contributed by Dr. Lorenzo Pavone.)

A composite diagram of these distribution patterns was then drawn that has subsequently been referred to as the lines of Blaschko. In 1976, Jackson introduced the concept of the lines of Blaschko into the English-language literature, although it had been well-known in the European community for decades (07). Happle added to Blaschko’s original diagram lines (confined to the trunk and limbs) localized to the posterior scalp (25; 07; 27).

Hypomelanosis of Ito. In 1952 Minor Ito described a 22-year-old Japanese girl whose skin of the upper half of her body looked as “if the normal pigment was brushed off.” The depigmented skin lesions were widespread and symmetric, arranged in irregular shapes with “zigzag borders and splash-like spots” on the trunk and in a “linear pattern” down her arms. He defined these lesions as “nevus depigmentosus systematicus bilateralis” (30). No other physical abnormality was reported apart from asymmetry of breast size. At that time, Ito coined the term incontinentia pigmenti achromians (45) because the pattern of color loss was similar to that of the hyperpigmented changes seen in incontinentia pigmenti of the Bloch-Sulzberger type (OMIM #308300). Subsequent observations expanded the phenotype, and the name hypomelanosis of Ito was proposed to avoid confusion with incontinentia pigmenti (32). However, this term was criticized because Ito’s original patient was described as having “depigmented,” not hypopigmented lesions (30; 61; 62; 51). Possibly, the original patient by Ito may have had incontinentia pigmenti, as the author himself believed (30). Further terms have been used such as Ito disease, Ito syndrome, and Ito hypomelanosis.

Proposed changes in terminology included the terms pigmentary dysplasia, mosaic dyspigmentation, pigmentary mosaicism, pigmentary mosaicism of the Ito type, or hypopigmentation along the lines of Blaschko to reflect the disease pathogenesis or recall the cutaneous patterns (12; 61; 15; 37; 62; 51; 45). Despite these criticisms, the term hypomelanosis of Ito is still used.

Clinical manifestations

Presentation and course

	• The main defining features of hypomelanosis of Ito are linear and whorled patterns of skin hypopigmentation along the lines of Blaschko.
	• Other organ systems commonly involved include hair, dental, ophthalmologic, musculoskeletal, and neurologic.
	• Neurologic manifestations most commonly include cognitive and behavioral symptoms and epilepsy, and are often accompanied by a wide spectrum of dysgenetic imaging findings on brain MRI.

Hypomelanosis of Ito is a multisystem disorder in which most organs of the body may show anomalies in addition to the skin. The most frequent alterations are found in the musculoskeletal and central nervous systems.

The main features that define hypomelanosis of Ito are the cutaneous anomalies.

Hypomelanosis of Ito typical skin lesions

Hypomelanosis of Ito patients showing the typical skin lesions distributed in linear arrangements in the face (a) and extremities (c), and in whorls and s-shaped patterns over the trunk (b). (Contributed by Dr. Lorenzo Pavone.)

In many instances, patients present with skin hypopigmentation following the lines of Blaschko without any other associated anomaly (38; 51). The frequency of cutaneous or extracutaneous abnormalities in published articles and reviews may reflect the detail of the investigation in the series or the population studied. For example Metzker and colleagues did not find extracutaneous involvement in an analysis of 30 children with hypomelanosis of Ito (36). Nehal and colleagues and Ruggieri and Pavone recorded low frequencies of extracutaneous abnormalities (30%) whereas Ruiz-Maldonado and colleagues reported nearly 100%, Pascual-Castroviejo and colleagues 94%, Glover and colleagues 79%, and Zvulunov and Esterly 75% (43; Grover et al 1989; 55; 71; 38; 51).

Skin manifestations. The pigmentary lesions in hypomelanosis of Ito are either recognizable at birth or become visible during early childhood. Unilateral or bilateral areas of hypopigmentation with irregular borders characterize the typical phenotype with lesions arranged in whorls, patches, or linear patterns along the lines of the Blaschko (26; 27).

Hypomelanosis of Ito typical skin lesions

This system of lines (Blaschko lines) forms streaks displaying a v-shape or fountain-like pattern over the face and spine and s-shaped or whorled patterns over the anterior and lateral aspects of the trunk, and a linear arrangement over the extremities with a characteristic sharp midline cutoff (06).

Lines of Blaschko

Drawing of the "lines of Blaschko" originally obtained by Blaschko after examining more than 100 cases of congenital skin lesions distributed in mosaic patterns. (Contributed by Dr. Lorenzo Pavone.)
Facial lesions in hypomelanosis of Ito

(Contributed by Dr. Lorenzo Pavone.)
Truncal lesions in hypomelanosis of Ito

Whorled patterns of the trunk in a child with hypomelanosis of Ito. (Contributed by Dr. Lorenzo Pavone.)
Linear lesions in hypomelanosis of Ito

Linear arrangement of skin lesions on the arm of a child with hypomelanosis of Ito. (Contributed by Dr. Lorenzo Pavone.)

The lines of Blaschko are always associated with mosaicism (26; 07). Pigmentary anomalies associated with human mosaicism may show several patterns of distribution in the skin: (1) type 1, typically following the lines of Blaschko (either narrow band, type 1a, or broad band, type 1b); (2) type 2, checkerboard pattern; (3) type 3, phylloid pattern; (4) type 4, patchy pattern without midline separation (26); and (5) type 5, spiral pattern (51; 45). Accordingly, other types of cutaneous pigmentary patterns, such as the zosteriform or dermatome or plaque-like arrangement, have likewise been observed in hypomelanosis of Ito. All of these cutaneous changes are associated with mosaicism, but not all are hypopigmented zones, and not all correspond to hypomelanosis of Ito skin patterns other than those following Blaschko lines.

The hypopigmented zones in hypomelanosis of Ito can be seen in any part of the body: head, face, neck, trunk, or extremities (they also have been observed in the iris) (58; 55; 44).

Facial lesions in hypomelanosis of Ito

(Contributed by Dr. Lorenzo Pavone.)
Truncal lesions in hypomelanosis of Ito

Whorled patterns of the trunk in a child with hypomelanosis of Ito. (Contributed by Dr. Lorenzo Pavone.)
Linear lesions in hypomelanosis of Ito

Linear arrangement of skin lesions on the arm of a child with hypomelanosis of Ito. (Contributed by Dr. Lorenzo Pavone.)

Areas of hyperpigmentation following the lines of Blaschko may also be seen as a counterpart to areas of hypopigmentation. In many patients, determination that the lighter areas of skin were hypopigmented rather than the darker areas hyperpigmented has been arbitrary (62). Areas of hypomelanosis are more easily detected in ethnic groups with increased skin pigmentation, such as Asians, Hispanics, or Africans. Inspection with a Wood (ultraviolet) lamp could help distinguish hypochromic zones, especially in Caucasians with fair skin (58). The extent of the hypopigmented cutaneous lesion does not always correlate either with the severity of neurologic disease or with the neuroimaging or histological findings (54). It is a necessary prerequisite that hypopigmented skin is not preceded by vesicular or verrucous stages because cutaneous lesions in the stage IV of incontinentia pigmenti are indistinguishable from those of hypomelanosis of Ito (26; 27).

Sweat glands and fingernails also may be abnormal (43; 55). Hypohidrosis corresponds to hypopigmented areas, which may represent a pathological cell line. This feature, however, has been found in about one third of patients with hypomelanosis of Ito (33). Absence of sweating with absence of glands in a skin biopsy has been reported, and this may be an argument in favor of the heterogeneity of hypomelanosis of Ito.

Other types of cutaneous lesions associated with hypomelanosis of Ito include café-au-lait spots, nevus marmorata, angiomatous nevi, nevus of Ota, and slate gray spots.

Scalp and hair. Scalp alterations mainly include changes in hair color, diffuse alopecia, and hair with trichorrhexis and white-grayish color (44; 51). Some patients show alopecia in areas of the scalp until 3 to 5 years of age, at which time trichorrhexis and grey-white hair may appear (43; 44). Patients with hair anomalies (mostly color changes) may show an increased frequency of systemic anomalies (including macrocephaly, hemicranial or hemifacial hypertrophy, ocular, nasal, or oral abnormalities, cerebral malformations, asymmetry of the trunk or extremities, and others) than patients without hair changes. Hypochromic hair may appear as areas of patches, streaks, or extending over the entire scalp, associated with achromic or hypochromic skin. Focal hypertrichosis of the genital area without signs of precocious puberty has been observed. In addition, multifocal hypertrichosis and hirsutism have also been reported (35).

Eye manifestations. Ocular alterations are rarely reported, and they are not specifically related to hypomelanosis of Ito. These include strabismus, nystagmus, dacryostenosis, hypertelorism, ptosis, symblepharon, nonclosure of the upper lid, myopia, amblyopia, iridal heterochromia, scleral melanosis, cataracts, striated patchy hypopigmented fundi, atrophy of the choroid, corneal opacity, micro-ophthalmia, macro-ophthalmia, optic nerve hypoplasia, and retinal degeneration (32; 58; 43; 55; 54; 51; 45).

Oral manifestations. Oral anomalies are of a wide variety and consist of defective dental implantation, partial anodontia, dental hypoplasia or dysplasia, conical teeth, and defective enamel (44). Hamartomatous cuspids protruding from the dental crowns of permanent teeth might be histologically reminiscent of odontoma. Bifid uvula and submucosal cleft palate are other unusual anomalies.

Musculoskeletal manifestations. Musculoskeletal disturbances are usually observed in more severe phenotypes (43; 55; 44). Skeletal defects include short stature and asymmetry with hemihypertrophy or hemihypotrophy of a part or of an entire side of the body (51; 45), scoliosis, thoracic deformities (pectus carinatum or excavatum), various finger and toe anomalies (clinodactyly, polydactyly, syndactyly, brachydactyly), and foot deformities (pes cavus, talipes equiinovarus) (32; 43; 44; 51; 64).

Hypertrophic or hypotrophic areas are usually seen on the same side as the hypomelanotic skin. Unilateral hypertrophy, also referred to as hemi-overgrowth, occurs in 7% of patients and is associated with a higher prevalence of extracutaneous manifestations (47). Bilateral hypertrophy is found in some cases with generalized hypomelanotic skin. The patients usually show coarse facies and macrocephaly (58, 43; 58, 44). All these defects are likely related to the age-dependent effect of the genetic mosaic abnormality (51; 51).

Nervous system manifestations. Anomalies of the CNS may include microcephaly or macrocephaly, cognitive and motor retardation, seizures, ataxia, hyperkinesias, and hypotonia (32; 43; 55; 54; 44; 51). They represent the most severe complications of hypomelanosis of Ito and there is a consistent discrepancy between the reported prevalence figures; by literature review, the incidence of associated neurologic disease was as high as 100% (28), 94% (43), or 80% (24), or as low as 61% (50), 50% (23), 40% (41), or 30% (38; 51).

Cognitive and behavioral problems. These are the most frequent neurologic problems in individuals with hypomelanosis of Ito. An IQ below 70 has been reported in 30% (38; 51), 57% (44), and 70% (55) of cases, likely depending on ascertainment bias in tertiary referral centers (51). Patients with mental retardation have been reported to exhibit autism spectrum disorders (43; 21; 01; 55; 70), but again the highest prevalence figures for autism in hypomelanosis of Ito (8% to 10%) are likely due to a bias toward child neuropsychiatry referrals (01; 70). Most patients with mental retardation, autism spectrum disorders, or both previously suffered infantile spasms or severe seizures (Pascual-Castroviejo 1989; 55; 44). The association of mental retardation with seizures is seen in 65% of cases (55; 54; 44).

Epilepsy. This is the second most frequent neurologic manifestation of hypomelanosis of Ito. Seizures may occur in 11% (38) to about 50% (43; 44) of cases. Seizures commonly appear early, within the first year of life and are mostly associated with cognitive deficits. Seizures can be refractory but are controlled with antiepileptic drugs in 70% (44). Epilepsy surgery can be successful in the carefully chosen candidate with medication-refractory epilepsy (48; 34). Seizure semiology is heterogeneous; of those patients with epilepsy, about 50% manifest as generalized tonic-clonic seizures, 25% as partial seizures, 15% as infantile spasms, and 8% as myoclonic seizures (44; 03; 46). There is no consistent EEG pattern in hypomelanosis of Ito. The EEG can yield normal results or show a wide range of abnormalities, with both focal and generalized epileptiform discharges (17; 39; 46).

Other neurologic manifestations. Speech delay in hypomelanosis of Ito has been occasionally reported with higher scores on performance IQ (mean PIQ = 90) than verbal IQ (mean VIQ = 73), delays in the production of speech sound and in communication milestones, and specific expressive language disabilities (70; 54). Other neurologic alterations found in isolated cases include muscular hypotonia, ataxia, neurosensorial deafness, and cortical visual impairment (51; 59).

Imaging findings. There are no constant findings in hypomelanosis of Ito, as expected. Most hypomelanosis of Ito cases (and likely almost all cases with no clinical neurologic signs or symptoms) display normal neuroimaging studies (04; 14) or only show enlarged perivascular spaces (54) to include the possibility of unilateral enlarged perivascular spaces (65). In the remainder, abnormalities may be grouped into white matter alterations and structural malformations (14). Nonprogressive white matter abnormalities on MRI (thought to be pathologically related to dilated Virchow-Robin spaces or altered/delayed myelination) may appear as early as a few months of age, and on T2-weighted and FLAIR sequences show multifocal, symmetric, high-signal foci in the periventricular and subcortical white matter, particularly in the centrum semiovale.

Hypomelanosis of Ito (MRI)

Axial T2-weighted image of the brain in a child with hypomelanosis of Ito showing high signal lesions in the posterior periventricular white matter. (Contributed by Dr. Lorenzo Pavone.)

CT shows the same features as multiple low-density areas in the deep white matter of the hemispheres or as diffuse low density in the white matter (when a large number of lesions are present) (14). White matter lesions are static over time (18) and show no correlation between the extent of the lesions and the patient age (54). The most frequent structural anomalies are cerebellar hypoplasia or atrophy, focal cerebral atrophy or generalized cerebral atrophy, cerebral dysplasias, or other migrational abnormalities rarely associated with hemimegalencephaly. Other anomalies include gray matter heterotopia, blurred gray/white matter junction, agyria, polymicrogyria, porencephaly, and periventricular cysts (51; 04; 14; 45). Rare cases have also been reported of hypomelanosis of Ito with Sturge-Weber syndrome-like unilateral leptomeningeal angiomatoses (19; 10).

Other system anomalies. These can include congenital cardiac disease (43; 55; 44), renal disease including single kidney or ureteral duplication, focal segmental glomerulosclerosis with end-stage renal disease, or glomerulocystic kidney disease (20; 66), and genitourinary anomalies including cryptorchidism, micropenis, or macrogenitosomia (43; 55; 44). Asymmetric breast development (30; 44), gynecomastia in either boys or prepubertal girls (43), and precocious puberty (42) have all been reported. Hypomelanosis of Ito occasionally is associated with vascular anomalies such as moyamoya disease (13), carotid artery aneurysms (11), aortic malformations (67), intracranial arteriovenous malformation, or intestinal lymphangiectasia. Finally, lung involvement with segmental pulmonary hypoplasia has also been reported (05).

Hypomelanosis of Ito and tumors. A limited number of hypomelanosis of Ito cases are occasionally associated with tumors, including cystic teratoma in association with diploic epidermoid cyst, complex mature sacrococcygeal dysembryoma tumor, choroid plexus papilloma, and dental hamartomatous tumor (complex composite odontome-like). Rarely, malignancies such as acute lymphoblastic leukemia, medulloblastoma, neuroblastoma, and retinoblastoma have been reported (52; 16).

Prognosis and complications

Approximately one third (or fewer) of patients with hypomelanosis of Ito and related disorders (depending on the reported series) have psychomotor delay in infancy and present with cognitive or behavioral deficits later in childhood. Approximately the same percentage presents some type of seizure. Seizures in these disorders may be refractory (43; 54), especially because of disordered neuronal migration (17). However, control of seizures in 70% of patients with hypomelanosis of Ito has been reported in series of Pascual-Castroviejo and colleagues and Ruggieri and Pavone (44; 51). Autistic spectrum disorders, even rarely, must be taken into consideration. Musculoskeletal and other systemic abnormalities are congenital and, thus, are not progressive.

Biological basis

	• Hypomelanosis of Ito mostly occurs sporadically, but the diagnosis likely encompasses a widely heterogenous genetic etiology.
	• There are rare case reports and case series describing familial occurrence and supporting occasional single gene occurrence.
	• Mosaicism is also a common contributor to the varied severities of phenotypic manifestations of hypomelanosis of Ito.

Etiology and pathogenesis

Mendelian transmission. There have been a number of single case reports claiming familial occurrence and supporting single gene inheritance (12; 51; 51; 45).

Two families were reported with a mother and her daughter and one family with a brother and sister affected by hypomelanosis of Ito (02; 68; 51). Members of the same family having hypomelanosis of Ito have been mentioned in other series (44). Paradominant inheritance has been claimed to be a possible mechanism in these families as well as in some non-Mendelian recurrences of hypomelanosis of Ito phenotypes running in families (27).

There have been reports on daughters from mothers with balanced X-autosome translocations with breakpoint above the juxtacentromeric X region with phenotypes overlapping with hypomelanosis of Ito (29).

Chromosome studies. The recognition of a variety of chromosomal mosaicisms (to include associations with trisomies such as trisomy 2 and 21) (22; 40), and ring chromosomes, such as ring chromosome 20 (08), as the pathogenic basis of many cases of hypomelanosis of Ito was a clue to explain the protean clinical manifestations of this condition and their often asymmetrical expression (61; 12; 51; 51). The primary question addressed is how such disparate genotypes could produce the common cutaneous phenotype of patchy pigmentation. By cross-comparing karyotype abnormalities in hypomelanosis of Ito and in cases with demonstrated pigmentary mosaicism with 76 pigmentary and candidate pigmentary gene loci, either in humans or animals, Taibjee and colleagues showed extensive (88%) overlaps between cytogenetic abnormalities and one or more pigmentary genes as well as significant (74%) overlaps between pigmentary genes and one or more karyotype abnormalities supporting the hypothesis that the pigmentary phenotype could arise through karyotype abnormalities specifically disrupting either expression or function of pigmentary genes (63; 45).

In hypomelanosis of Ito the pigmentary phenotype could arise through karyotype abnormalities specifically disrupting either expression or function of pigmentary genes. Likely mechanisms to explain the disruption are (63; 45): (1) parallel comigration of genetically different but not necessarily abnormal cell clones; (2) X-chromosome functional disomy; (3) “spreading” of X inactivation to autosomes; (4) transposons (transposable elements of retroviral origin) regulating gene activation and silencing and modulating the activity of pigmentary genes; (5) genetic imprinting; and (6) phenotype reversion. None of these, however, has so far been demonstrated as the likely mechanism to explain hypomelanosis of Ito. The various processes controlled by the (disrupted) pigmentary genes are: (1) melanoblast migration from the neural crest in fetal life; (2) melanocytes function including synthesis, transport, and degradation of melanosomes; and (3) physiology of the surrounding melanocytes milieu that include keratinocytes, intercellular matrix, growth factors, etc. It is unknown, however, at which level the process is disrupted. Sarnat and Flores-Sarnat hypothesized that the lines of Blaschko and hypomelanotic whorls and patches may represent a disorder of neural crest migration and terminal differentiation of melanocytes (56).

In addition, rare mosaic single-gene anomalies have been reported to include mosaic-activating mTOR (mechanistic target of rapamycin) pathogenic variants, identified within both brain and skin biopsies. The clinical spectrum of mTOR-related hypomelanosis of Ito can include patients with features of macrocephaly, hemimegalencephaly, intellectual disability, and epilepsy (09).

Differential diagnosis

Confusing conditions

Hypomelanosis of Ito presents many similarities with other diseases with hypopigmented spots on the skin. These diseases are incontinentia pigmenti of Bloch and Sulzberger (OMIM #308300), tuberous sclerosis (OMIM #191100), vitiligo, and skin fungal infections.

Identical to hypomelanosis of Ito, incontinentia pigmenti shows the streaky pigmentary changes and the frequent occurrence of extracutaneous abnormalities. Hypomelanosis of Ito also differs from classical incontinentia pigmenti in the absence of preceding inflammatory or verrucous lesions and the occurrence of a much wider spectrum of associated abnormalities. Furthermore, hypomelanosis of Ito occurs as a sporadic trait (51; 63), whereas incontinentia pigmenti is X-linked and now known to be due to mutations of the IKBKG (NEMO) gene (60). Incontinentia pigmenti is also characterized by affecting almost only females and by a dynamic course of distinct cutaneous lesions that appear successively soon after birth, which include: (1) linear dermatitis with vesicles and erythema, (2) linear verrucous anomalies, (3) hyperpigmented streaks, and (4) hypochromic or achromic lesions similar to those of hypomelanosis of Ito. In contrast to incontinentia pigmenti, the hypopigmentation in patients with hypomelanosis of Ito is either recognized at birth, during the neonatal period, or in early childhood and remains unchanged for many years or for the entire life.

Cutaneous lesions in tuberous sclerosis present as multiple independent spots, irregularly bordered, and frequently have the characteristic ash-leaf configuration. In addition, brain MRIs in tuberous sclerosis have specific characteristics (ie, cortical-subcortical tubers, subependymal nodules, radial white matter abnormalities, calcifications, and more rarely subependymal cell astrocytoma).

Vitiligo is a straightforward diagnosis for dermatologists.

Skin fungal lesions are local problems of the skin that do not involve the CNS and can disappear after a variable period of time, whereas cutaneous lesions of hypomelanosis of Ito do not disappear. Wood lamp examination and superficial skin biopsies could help the differential diagnosis.

Misdiagnosis of hypomelanosis of Ito. In the absence of a recognized diagnosis, the label of hypomelanosis of Ito has often been used for individuals having diffuse or patchy, generalized or limited, linear or spotty skin dyspigmentation or hypopigmentation in many patchy or streaky configurations. This has caused great confusion and has expanded the phenotype of hypomelanosis of Ito, melting under the same rubric several conditions of different etiologies solely because of the presence of hypopigmented skin lesions. Often, in such cases, the presumptive diagnosis of a child having CNS or musculoskeletal abnormalities associated with cutaneous anomalies has been based only on a single or a pair of pigmentary skin lesions that could ultimately have been merely a presenting symptom of other diseases (51; 51). Notably, in the London Dysmorphology Database, there are more than 70 different syndromes (including hypomelanosis of Ito) under the same entry, “patchy depigmentation of skin” (69). Thus, we would favor the use of the term hypomelanosis of Ito (and related disorders) only in cases with “overt” and “widely distributed” pigmentary abnormalities, with or without associated extracutaneous manifestations.

Linear and whorled nevoid hypermelanosis. Linear and whorled nevoid hypermelanosis is a sporadic disorder characterized by (49): (1) asymmetrically distributed linear and whorled hyperpigmentation following Blaschko lines as well as reticulated hyperpigmentation; (2) coexistence (in some cases) of hyper- and hypopigmented lesions in the same patient; (3) skin lesions noted at birth or within the first 2 years of life; (4) no preceding inflammatory event or palpable lesion; (5) gradual increase (spread) of involvement during the first 2 years of life and subsequent stabilization or gradual fading; (6) sparing of mucous membranes, palms, and soles; (7) sporadic male and female (equal) incidence; (8) increased pigmentation of the basal layer and prominence or vacuolation of melanocytes, with no pigment incontinence or dermal melanophages on histological examination; and (9), in approximately 30% of cases (07; 38), associated systemic anomalies consisting in atrial septal defects, dextrocardia, mild hypereosinophilia, cerebral palsy, psychomotor delay, seizures, and deafness.

Under the term linear and whorled nevoid hypermelanosis two different clinical presentations may be included corresponding to the same spectrum: (1) the classical generalized pattern with onset within the first 2 weeks of life; and (2) unilateral cases involving only one quadrant of the body, with a later onset at about the second decade of life.

Phylloid hypomelanosis. The so-called phylloid hypomelanosis (previously regarded as a hypomelanosis of Ito-related disorder) appears to be constantly associated to trisomy 13 mosaicism (57) and, therefore, is ruled out on a cytogenetic basis.

Diagnostic workup

	• The diagnosis of hypomelanosis of Ito is clinical, based on physical examination and imaging features.
	• Genetic consultation is often helpful, especially in familial cases, to help understand and contribute to the known genetic etiologies that can cause hypomelanosis of Ito.

Patients who exhibit pigmentary anomalies (hypopigmentation or depigmentation or hyperpigmentation) along the lines of Blaschko, in a patchy or linear distribution, unilaterally or bilaterally, should be fully evaluated for structural systemic abnormalities. Laboratory or imaging tests, including EEG and neuroimaging, should be only oriented by the abnormal findings on clinical examination. Karyotyping of peripheral blood, and if this is normal, skin fibroblasts or better keratinocytes or melanocytes obtained from biopsies taken from affected and unaffected areas, should be performed in affected individuals to support the diagnosis.

Histopathology. Regarding follow-up controls, each case should be examined individually and further evaluated to the extent that the history, careful clinical examination, and investigations dictate more frequent re-evaluations in children with unusual symptoms or complications requiring special care. Parents should be reassured that serious complications, if present, are congenital and, thus, typically evident clinically early in infancy. The chance occurrence of a tumor in an affected patient should be almost the same as in the general population.

The routine or screening use of brain MRI does not improve hypomelanosis of Ito prognosis because the majority of CNS abnormalities are either unspecific or not treatable and overall do not predict a poor outcome. Conversely, a full brain MRI study is warranted if and when seizures ensue because some patients could have underlying neuronal migration anomalies.

Media

References

01: Akefeldt A, Gillberg C. Hypomelanosis of Ito in three cases with autism and autistic-like conditions. Dev Med Child Neurol 1991;33:737-43. PMID 1717328
02: Amon M, Menapace R, Kirnbauer R. Ocular symptomatology in familial hypomelanosis of Ito. Ophthalmologica 1990;200:1-6. PMID 2320353
03: Assogba K, Ferlazzo E, Striano P, et al. Heterogeneous seizure manifestations in Hypomelanosis of Ito: report of four new cases and review of the literature. Neurol Sci 2010;31(1):9-16. PMID 19902142
04: Barkovich AJ. The phakomatoses. In: Barkovich AJ, editor. Pediatric Neuroimaging. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:440-505.
05: Bhat RY, Patra S, Varma PV, Prakashini K. Hypomelanosis of Ito with an unusual pulmonary abnormality in an infant. Indian Dermatol Online J 2014;5(2):196-7. PMID 24860762
06: Blaschko A. Der Nervenverteilung in der Haut ihrer Bezielung zu den Erkrankungen der Haut. Wien: Wilhelm Braumuller, 1901.
07: Bologna JL, Orlow SJ, Glick SA. Lines of Blaschko. J Am Acad Dermatol 1994;31:157-90. PMID 8040398
08: Cappanera S, Passamonti C, Zamponi N. New association between ring chromosome 20 syndrome and hypomelanosis of Ito. Pediatr Neurol 2011;45:341-3. PMID 22000318
09: Carmignac V, Mignot C, Blanchard E, et al. Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities. Genet Med 2021;23(8):1484-91. PMID 33833411
10: Degerliyurt A, Kantar A, Ceylaner S, Aysun S. Hypomelanosis of Ito and Sturge-Weber syndrome without facial nevus: an association or a new syndrome? Pediatr Neurol 2009;40:395-7. PMID 19380080
11: Demartini Z, Teixeira BC, Koppe GL. Carotid artery aneurism and hypomelanosis of Ito. Pediatr Neurosurg 2023;58(2);114-6. PMID 37011605
12: Donnai D. Pigmentary mosaicism: hypomelanosis of Ito. In: Donnai D, Winter RM, editors. Congenital Malformation Syndromes. London: Chapman & Hall, 1996:379-85.
13: Echenne BP, Leboucq N, Humbertclaude V. Ito hypomelanosis and moyamoya disease. Pediatr Neurol 1995;13:169-81. PMID 8534285
14: Edelstein S, Naidich TP, Newton TH. The rare phakomatoses. In: Tortori-Donati P, editor. Pediatric Neuroradiology. Brain. Berlin: Springer, 2005:819-54.
15: Editorial. Hypomelanosis of Ito. Editorial. Lancet 1992;339:651-2. PMID 1347343
16: El-Sawy T, He L, Chiang MF, et al. Retinoblastoma presenting in a child with hypomelanosis of Ito. Open Ophthalmol J 2011;5:55-8. PMID 22216075
17: Esquivel EE, Pitt MC, Boyd SG. EEG findings in hypomelanosis of Ito. Neuropediatrics 1991;22:216-9. PMID 1775218
18: Fryburg JS, Lin KY, Matsumoto J. Abnormal head MRI in a neurologically normal boy with hypomelanosis of Ito. Am J Med Genet 1996;66:200-3. PMID 8958331
19: García Muret MP, Puig L, Allard C, Alomar A. Hypomelanosis of Ito with Sturge-Weber syndrome-like angtiomatosis. Pediatr Dermatol 2002;19:536-40. PMID 12437559
20: Gatter N, Hoppe B, Nutzenadel F, Waldherr R, Querfeld U. A cutaneous disease with multisystem involvement: hypomelanosis of Ito may be associated with proteinuria, focal segmental glomerulosclerosis, and end-stage renal disease. Nephrol Dial Transplant 2007;22(6):1796-8. PMID 17347282
21: Glover MT, Brett EM, Atherton DJ. Hypomelanosis of Ito: spectrum of the disease. J Pediatr 1989;115:75-80. PMID 2738798
22: Gupta S, Shah S, McGaw A, Mercado T, Zaslav AL, Tegay D. Trisomy 2 mosaicism in hypomelanosis of Ito. Am J Med Genet 2007;15:2466-8. PMID 17853474
23: Hamada T, Saito T, Sugai T, Morita Y. "Incontinentia pigmenti achromians (Ito)." Arch Dermatol 1967;96:673-6. PMID 6075785
24: Hamada K, Tanaka T, Ohdo S, Hayakawa K, Kikuchi I, Katsuya H. Incontinentia pigmenti achromians as part of a neurocutaneous syndrome: a case report. Brain Dev 1979;1:313-7. PMID 553451
25: Happle R. Lyonization and the lines of Blaschko. Hum Genet 1985;70:200-6. PMID 3894210
26: Happle R. Mosaicism in human skin. Understanding the patterns and mechanisms. Arch Dermatol 1993;129:1460-70. PMID 8239703
27: Happle R. Principles of genetics, mosaicism, and molecular biology. In: Harper J, Oranje A, Prose N, editors. Textbook of Pediatric Dermatology. 2nd ed, Oxford: Blackwell Publishing, 2006:1221-46.
28: Hara M, Kozasa M, Mituisi Y, Yajima K, Saito K, Fukuyama Y. Ito syndrome (Hypomelanosis of Ito) as a cause of intractable epilepsy. In: Pascual-Castroviejo I, editor. Trastornos neuroectodérmicos. Barcelona: JR Prous, 1989:221-5.
29: Hatchwell E. Hypomelanosis of Ito and X; autosome translocations: a unifying hypothesis. J Med Genet 1996;33:177-83. PMID 8728687
30: Ito M. Studies of melanin XI. Incontinentia pigmenti achromians: a singular case of nevus depigmentosus systematicus bilateralis. Tohoku Exper Med 1952;55(suppl):57-9.
31: Jackson R. The lines of Blaschko: a review and reconsideration of observations on the cause of certain unusual linear conditions of the skin. Br J Dermatol 1976;95:349-60. PMID 788770
32: Jelinek JE, Bart RS, Shiff GM. Hypomelanosis of Ito (“Incontinentia pigmenti achromians”). Arch Dermatol 1973;107:596-601. PMID 4633268
33: Kuster W, Konig A. Hypomelanosis of Ito: no entity, but a cutaneous sign of mosaicism. Am J Med Genet 1999;85:346-50. PMID 10398257
34: Manjila S, Miller BR, Goodman A, et al. Pharmacoresistant epilepsy in hypomelanosis of Ito: palliative surgical treatment with modified anatomic posterior quadrant resection. Clin Neurol Neurosurg 2014;123:15-7. PMID 25012005
35: Mendiratta V, Yadav A, Pagnti R, Chander R. An interesting coexistence of multifocal hypertrichosis and hirsutism in hypomelanosis of Ito. Indian Dermatol Online J 2019;10:316-8. PMID 31149581
36: Metzker A, Morag C, Weitz R. Segmental pigmentation disorder. Acta Derm Venereol 1983;63:167-9. PMID 6189338
37: Moss C, Larkins S, Stacy M, Blight A, Ferndon PA, Davison EV. Epidermal mosaicism and Blaschko's lines. J Med Genet 1993;30:752-5. PMID 8411070
38: Nehal KS, Pe Benito R, Orlow SJ. Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch Dermatol 1996;132:1167-70. PMID 8859026
39: Ogino T, Hata H, Minakuchi E, Iyoda K, Narahara K, Ohtahara S. Neurophysiologic dysfunction in hypomelanosis of Ito: EEG and evoked potential studies. Brain Dev 1994;16:407-12. PMID 7892963
40: Okanari K, Miyahara H, Itoh M, et al. Hemimegalencephaly in a patient with coexisting trisomy 21 and hypomelanosis of Ito. J Child Neurol 2014;29(3):415-20. PMID 23266943
41: Ortonne JP, Coiffet J, Floret D. Hypomelanosis of Ito: report of one case (author's transl). Ann Dermatol Venereol 1979;106:47-50. PMID 114089
42: Park JM, Kim HJ, Kim T, Chae HW, Kim DH, Lee MG. Sexual precocity in hypomelanosis of Ito: mosaicism-associated case report and literature review. Int J Dermatol 2011;50:168-74. PMID 21244380
43: Pascual-Castroviejo I, Lopez Rodriguez L, de la Cruz Medina M, Salamanca Maesso C, Roche Herrero C. Hypomelanosis of Ito. Neurological complications in 34 cases. Can J Neurol Sci 1988;15:124-9.** PMID 3383022
44: Pascual-Castroviejo I, Roche C, Martinez-Bermejo A, Arcas J, Lopez-Martin V, Tendero A. Hypomelanosis of Ito. A study of 76 infantile cases. Brain Dev 1998;20:36-43.** PMID 9533559
45: Pascual-Castroviejo I, Ruggieri M. Hypomelanosis of Ito and related disorders. In: Ruggieri M, Pascual-Castroviejo I, Di Rocco I, editors. Neurocutaneous Disorders: The Phakomatoses. New York-Vienna: Springer, 2007:235-65.
46: Pavone P, Pratico AD, Ruggieri M, Falsaperia R. Hypomelanosis of Ito: a round on the frequency and type of epileptic conditions. Neurol Sci 2015;36(7):1173-80. PMID 25586695
47: Pavone V, Signorelli SS, Pratico AD, et al. Total hemi-overgrowth in pigmentary mosaicism of the (hypomelanosis of) Ito type: eight case. Medicine 2016;95(10):e2705. PMID 26962770
48: Placantonakis DG, Ney G, Edgar M, Souweidane M, Hosain S, Schwartz TH. Neurosurgical management of medically intractable epilepsy associated with hypomelanosis of Ito. Epilepsia 2005;46(2):329-31. PMID 15679517
49: Quecedo E, Febrer I, Aliaga A. Linear and whorled naevoid hypermelanosis. A spectrum of pigmentary disorders. Pediatr Dermatol 1997;14:247-8. PMID 9192428
50: Rosemberg S, Artia FN, Campos C, Alonso F. Hypomelanosis of Ito. Case report with involvement of the central nervous system and review of the literature. Neuropediatrics 1984;15:52-5. PMID 6709127
51: Ruggieri M. Familial hypomelanosis of Ito: implications for genetic counseling. Am J Med Genet 2000;95:82-4. PMID 11074501
52: Ruggieri M, Magro G, Polizzi A. Tumours and hypomelanosis of Ito. Arch Pathol Lab Med 2001;125:599-601. PMID 11339219
53: Ruggieri M, Pavone L. Hypomelanosis of Ito: clinical syndrome or just phenotype. J Child Neurol 2000;15:635-44. PMID 25615839
54: Ruggieri M, Tigano G, Mazzone D, Tiné A, Pavone L. Involvement of the white matter in hypomelanosis of Ito (incontinentia pigmenti achromiens). Neurology 1996;46:485-92. PMID 8614519
55: Ruiz-Maldonado R, Toussaint S, Tamayo L, Laterza A, del Castillo V. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol 1992;9:1-10.** PMID 1574469
56: Sarnat HB, Flores-Sarnat L. Embriology of the neural crest: its inductive role in the neurocutaneous syndromes. J Child Neurol 2005;20:637-43. PMID 16225807
57: Schepis C, Failla P, Siragusa M, Romano C. An additional case of macular phylloid mosaicism. Dermatology 2001;202:73. PMID 11244237
58: Schwartz MF, Esterly NB, Fretzin DF, Pergament E, Rozenfeld IH. Hypomelanosis of Ito (incontinentia pigmenti achromians): a neurocutaneous syndrome. J Pediatr 1977;90:236-40. PMID 830915
59: Scott A, Micallef C, Hale SL, Watts P. Cortical visual impairment in hypomelanosis of Ito. J Pediatr Ophthalmol Strabismus 2008;45(4):240-1. PMID 18705622
60: Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000;405:466-72. PMID 10839543
61: Sybert VP. Hypomelanosis of Ito. Pediatr Dermatol 1990;7:74-6. PMID 2343010
62: Sybert VP. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol 1994;103:141S-3S. PMID 7963677
63: Taibjee SM, Bennett DC, Moss C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. B J Dermatol 2004;151:269-82. PMID 15327534
64: Tragardh M, Thomsen CR, Thorninger R, Moller-Madsen B. Hypomelanosis of Ito presenting with orthopedic issues: a case report. J Med Case Rep 2014;8:156. PMID 24886611
65: Ucar CI, Yildirim M, Sayar Y, Sahin S, Teber ST. Hypomelanosis of Ito presenting with unilateral dilation of Virchow-Robin spaces: a case report. Child Nerv Syst 2021;37(9):2931-4. PMID 33585955
66: Vergine G, Mencarelli F, Diomedi-Camassei F, et al. Glomerulocystic kidney disease in hypomelanosis of Ito. Pediatr Nephrol 2008;23(7):1183-7. PMID 18392644
67: Vivas D, Garcia-Guereta L, Montserrat B, et al. Hypoplasia of the abdominal aorta and hypomelanosis of Ito. Circulation 2009;120:2025-6. PMID 19917896
68: Vormittag W, Ensinger C, Raff M. Cytogenetic and dermatoglyphic findings in a familial case of hypomelanosis of Ito (incontinentia pigmenti achromians). Clin Genet 1992;41:309-14. PMID 1623628
69: Winter RM, Baraitser M. The London dysmorphology database & London neurogenetics database. Version 6.6. Oxford: Oxford University Press, 2006.
70: Zappella M. Autism and hypomelanosis of Ito in twins. Dev Med Child Neurol 1993;35:826-32. PMID 8354433
71: Zvulunov A, Esterly NB. Neurocutaneous syndromes associated with pigmentary skin lesions. J Am Acad Dermatol 1995;32:915-35. PMID 7751461

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

David T Hsieh MD

Dr. Hsieh of the Uniformed Services University of the Health Sciences has no relevant financial relationships to disclose.
See Profile

Editor

Harvey B Sarnat MS MD FRCPC

Dr. Sarnat of the University of Calgary has no relevant financial relationships to disclose.
See Profile

Former Authors

Ignacio Pascual-Castroviejo MD (original author), Martino Ruggieri MD PhD, and Lorenzo Pavone MD

Patient Profile

Age range of presentation: 0 month to 12 years
Sex preponderance: female>male, 1:1
Heredity: heredity may be a factor

paradominant heredity
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-9: Other specified anomalies of skin: 757.3
ICD-10: Other congenital malformations of the skin: Q82
OMIM: Hypomelanosis of Ito: *300337

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Hypomelanosis of Ito

Associated Disorders

Chromosomal mosaicism

Differential Diagnosis

incontinentia pigmenti of Bloch-Sulzberger
tuberous sclerosis
vitiligo
skin fungal infections
linear and whorled nevoid hypermelanosis
- phylloid hypomelanosis

Also Relevant

Epilepsy
Hemimegalencephaly
Incontinentia pigmenti
Mental retardation
Neurocutaneous syndromes

Hypomelanosis of Ito …

Hypomelanosis of Ito

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Cerebro-oculo-facio-skeletal syndrome

Schizencephaly

Fetal anticonvulsant syndrome

Rhombencephalosynapsis

Malformations of the brain

Von Hippel-Lindau disease

Vein of Galen malformations

Hypomelanosis of Ito

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Cerebro-oculo-facio-skeletal syndrome

Schizencephaly

Fetal anticonvulsant syndrome

Rhombencephalosynapsis

Malformations of the brain

Von Hippel-Lindau disease

Vein of Galen malformations

This is an article preview.
Start a Free Account
to access the full version.